Insights into the Relevance of the Interaction between Colorectal Cancer and Gut Microbiota-Derived Metabolites

Read full text Summarise with VIRAT
Authors: Eun-Ju Kim, Sun‐Young Hwang, Kyoung-Ok No, Mee-Hyun Lee
Cited by: 0
References: 90

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Colorectal cancer (CRC) is strongly associated with gut microbial dysbiosis, characterized by increases in Escherichia coli, Enterococcus faecalis, and Bacteroides spp., and reduction in short chain fatty acid producing taxa such as Akkermansia muciniphila, Faecalibacterium prausnitzii, and Roseburia.These shifts parallel metabolomic disturbances, including decreased butyrate and immune dysregulation.Several microbial and metabolic markers such as Akkermansia, Faecalibacterium, butyrate, tryptophan metabolites, and sarcosine have demonstrated strong diagnostic performance, with area under the receiver operating characteristic curve (AUC) values commonly ranging from 0.80 to 0.93 in CRC prediction models.This review integrates current evidence for microbes and metabolite interactions that drive CRC progression and summarizes biomarker studies employing high AUC microbial and metabolite signatures for early detection and patient stratification.We further highlight phytochemicals, including resveratrol, curcumin, and quercetin which mitigate CRC by modulating cyclooxygenase-2 activity, macrophage polarization, inflammatory cytokine signaling, metabolic pathways, and the restoration of beneficial gut microbial communities.These insights support the advancement of microbiome targeted and metabolite informed approaches for CRC risk assessment, diagnosis, and therapeutic development.

Fields of Study & Subjects

Gut microbiota and health Colorectal Cancer Treatments and Studies Metabolomics and Mass Spectrometry Studies

Publication details

Journal / source
Journal of Cancer Prevention
Volume
31
Issue
3
Pages
140–152
Publication date
23 March 2026
Language
EN